The promise and challenges of deep learning models for automated histopathologic classification and mutation prediction in lung cancer
Pradnya Dinkar Patil, Brian Paul Hobbs, Nathan A. Pennell · Journal of Thoracic Disease · 2019
The histologic subclassification of tumors as either squamous cell carcinoma or adenocarcinoma is used by convention to guide systemic chemotherapy for patients diagnosed with non-small cell lung cancer (NSCLC) (1,2). The current gold standard for histopathologic classification of tissue specimens is visual microscopic inspection of tissue specimens by pathologists.